Albany - New York, Sept. 28, 2016 -- A market study on the global tourism market, recently published by Transparency Market Research (TMR) estimates this market to rise at an exceptional CAGR of 17.90% over the period from 2013 to 2019 and reach a value US$32.5 bn by the end of the forecast period.The research report, titled “Medical Tourism Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” states that the worldwide medical tourism market attained a value of US$10.5 bn in 2012.
Browse full Industry Research Report: http://www.transparencymarketresearch.com/medical-tourism.html
Medical tourism is defined as traveling from one location to another with a purpose to gain medical assistance. Generally, people from developing nations travel to developed countries for medical treatments that are unavailable in their own countries due to poor medical and healthcare infrastructure. However, in recent years, people residing in developed economies have also begun travelling to lesser developed countries in order to gain cost-efficient medical assistance.
According to this study, the falling cost of medical procedures in the Philippines, India, Singapore, Thailand, Mexico, Malaysia, Brazil, Turkey, Taiwan, South Korea, Poland, Costa Rica, and Dubai is encouraging people to travel to these countries for their treatment and, in turn, is propelling the global medical tourism market significantly.
In addition, the widening range of medical treatments available in these nations, coupled with technical advancements in the field of medical and healthcare, is likely to boost this market greatly during the forecast period, states the market report.
In this study, the global medical tourism market is analyzed on the basis of its regional spread. India, Singapore, Thailand, Malaysia, Brazil, Mexico, Turkey, Taiwan, and South Korea are the major medical tourism markets across the world.
Get Research PDF for more Professional and Technical Insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=900
Thailand has emerged as the most popular destination for cosmetic surgeries among the medical tourists from Western Europe. In 2012, this country had welcomed around 2.5 million foreign patients, accounting for approximately 45% of the overall number of foreign medical tourists arrived in Asia. However, Malaysia is likely to dominate the global medical tourism market in the coming years.
Almost 0.7 million patients were treated in this nation in 2012. Analysts expect around 2 mn patients to gain medical assistance in Malaysia by the end of the forecast period, notes the research report.
The report further states that India and Singapore are the most preferred destinations in case of complex medical procedures. India has attracted a large number of patients due to its increasing popularity in the field of cardiac treatments. Costa Rica, Dubai, Poland, and the Philippines have been identified as the prospective countries for medical tourism in this market study.
Samitivej Sukhumvit, Raffles Medical Group, Fortis Healthcare Ltd., Apollo Hospitals Enterprise Ltd., Bangkok Hospital Medical Center, Asian Heart Institute, Bumrungrad International Hospital, KPJ Healthcare Berhad, Min-Sheng General Hospital, and Prince Court Medical Center are some of the major organizations operating in the global medical tourism market.
Browse Press Release on Medical Tourism Market: http://www.transparencymarketresearch.com/pressrelease/medical-tourism.htm
The global medical tourism market is segmented into:
By Region
- India
- Thailand
- Singapore
- Malaysia
- Mexico
- Brazil
- Turkey
- South Korea
- Taiwan
- Prospective Countries
- Costa Rica
- Poland
- Dubai
- Philippines
Browse Other Research Reports:
- Traveler’s Diarrhea Market: http://www.transparencymarketresearch.com/travelers-diarrhea-market.html
- Mobility Scooter Market: http://www.transparencymarketresearch.com/mobility-scooter-market.html
- Care Management Solutions Market: http://www.transparencymarketresearch.com/care-management-solutions-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact Us: Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 



